Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorAvtandil M. Babunashvili

About this trial

The goal of this clinical trial is to learn immediate and follow up results of percutaneous treatment of coronary bifurcation lesion using drug eluting balloons (DEB) only in patients with chronic coronary syndrome (CCS). Researchers will compare endovascular treatment using solely DEB to stenting of coronary bifurcation lesion. The main questions it aims to answer are:

* What is immediate and follow up clinical and angiographic results of endovascular treatment of coronary bifurcation lesion using DEB in patients with CCS? * Is efficacy and safety of endovascular treatment of coronary bifurcation lesion using DEB only in patients with CCS non inferior to compare stenting of aforementioned lesion which is contemporary recommended standard of care?

Participants will:

* Take prescribed medication before and after initial procedure during whole observation period (12 months) * Visit the clinic at 1, 6 and 12 months after the initial procedure for checkup, noninvasive tests and control angiography at 12 months follow up * Inform researchers about all adverse events that might be occur during follow up observation period

Eligibility criteria

Qualifiers

Patients with CCS with documented myocardial ischemia in area supplying by the target coronary artery, not older than 80 years and with an expected life expectancy of at least 1 year

Patients with single- or multivessel disease and "true" (1.1.1; 1.1.0; and 0.1.1 according to the Medina classification) de novo bifurcation stenosis > 50% and <100% of the main coronary artery (excluding of the left main) or their large side branches.

Both main and side branches should be ≥ 2.0 mm and ≤ 4.5 mm in diameter (according to Quantitative coronary angiography - QCA or intravascular imaging)

Length of the main branch lesion should be no more than 30 mm

Disqualifiers

Patients with a single remaining artery supplying a large area of myocardium at risk, regardless of its caliber

Over 80 years of age

Bifurcation stenosis of the left main coronary artery and bifurcation lesions other than 1.1.1; 1.0.1, and 0.1.1 according to the Medina classification

The difference between the proximal and distal reference diameter of the main artery is > 1 mm

Trial design

Treatments tested in this trial

  • Balloon Angioplasty with or without drug administration

Treatment groups

272 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Avtandil M. Babunashvili

Lead sponsor

Center of Endosurgery and Lithotripsy, Moscow, Russia

Sponsor institution

I.M. Sechenov First Moscow State Medical University

Collaborator